StockTipsArenaBeta

CORONA Remedies Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹2,441.1+61.30 (+2.58%)
As of 6 Nov 2026

Only one active 1–3 month target

The short-term call is BUY

₹2,90018.8% above today's price

CORONA Remedies has one active 1–3 month share price target: ₹2,900 from MarketSmith India (4 Nov 2026). One target is a single view, not a consensus.

1
1 BUY · 0 SELL, all horizons
1
with an active 1–3M target
N/A
1 of 10 closed calls needed
2
all horizons, open and closed
Watch CORONA for new buy/sell callsGet alertsSee 48 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (2)

BUYTarget₹2,345
KSbyKotak SecuritiesTarget hit
1 Year · 3 Nov 2026 · entry ₹2,171.1 · via CNBC Awaaz.exit ₹2,345
BUYTarget₹2,900
MIbyMarketSmith India+18.8% to target
1–3 Months · 3 mo left · 4 Nov 2026 · entry ₹2,271.7 · via LiveMint Buy-or-Sell (topic)P&L +7.5%

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks